research use only
Cat.No.S3729
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | 736.06 | Formula | C18H24Fe2O24 |
Storage (From the date of receipt) | |
|---|---|---|---|---|---|
| CAS No. | 8047-67-4 | Download SDF | Storage of Stock Solutions |
|
|
| Synonyms | Iron saccharate, Sucroferric oxyhydroxide | Smiles | C(C(C(C(=O)[O-])O)O)(C(C(=O)[O-])O)O.C(C(C(C(=O)[O-])O)O)(C(C(=O)[O-])O)O.C(C(C(C(=O)[O-])O)O)(C(C(=O)[O-])O)O.[Fe+3].[Fe+3] | ||
| In vitro |
Iron sucrose (0.01 mg/mL) used as an additive to culture medium for 24 h was cytotoxic to human peritoneal mesothelial cells in in vitro culture as reflected by its effect on the cells' growth, viability and synthesis of IL-6; all these effects were dosedependent. At higher, concentrations cytotoxic effects of this compound appeared. Toxic effect of this chemical towards the mesothelial cells may be linked to increased production of free radicals. It enters into the cytosol of the mesothelial cells, where it is probably transported in a process of endocytosis.
|
References |
|---|
(data from https://clinicaltrials.gov, updated on 2024-05-22)
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT05921968 | Not yet recruiting | Iron Deficiency Anemia |
Ain Shams University |
July 30 2023 | Phase 4 |
| NCT04304625 | Recruiting | Postpartum Hemorrhage |
University Hospital Bordeaux |
August 7 2020 | Phase 3 |
| NCT03917394 | Unknown status | Anemia Iron Deficiency |
Peking Union Medical College Hospital |
April 24 2019 | -- |
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.